• Clinical Insights

Webinar: Ways to Overcome Staffing Shortages in Behavioral Health

Apr 6th, 2022

During Genoa’s recent webinar, Brad McMonigle, chief clinical officer at The Talbert House in Cincinnati, Ohio, and Liz Hegarty, PharmD, director of operations at Genoa, held a discussion on how staffing shortages are affecting behavioral health and ways to minimize the impact they’re causing.

McMonigle and Hegarty address:

  • How staffing shortages are affecting behavioral health care
  • Ways to minimize the impact they’re causing both staff and consumers
  • Reducing daily burden for clinic staff by maximizing the use of an integrated pharmacy partner and their services

Watch the recording to learn how a dedicated pharmacy partner can help fill in gaps for your consumers and staff.

Webinar attendees agreed that aside from direct patient care, medication management is one of the most time-consuming tasks for their clinic nursing staff. An integrated pharmacy partner acts as part of the consumer’s care team, leading to better health outcomes for your patients and a lighter workload for clinic staff.

We can help your team with:

  • Medication synchronization
  • Long-acting injectable (LAI) administration – see if your state is eligible
  • Medication assisted treatment
  • Prior authorization assistance
  • Adherence packaging
  • Medication delivery

Please contact us today to learn more about how our team can help.

If you are a current partner with Genoa, please reach out to your director of operations to get access to Med Analyzer – a tool used to track medication adherence for your consumers.

Recent Posts


  • Behavioral Health
  • Clinical Insights
  • Treatment
Why medication-assisted treatment is essential for improving patient outcomes

1. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH. 2. Methadone and buprenorphine reduce risk of death after opioid overdose. (2018, June 19). NIH....

  • 340B
Your questions, answered: 340B manufacturer pricing restrictions

Drug manufacturers began implementing restrictions for 340B pricing in 2020, citing alleged misuse by safety-net providers and explosive growth of the 340B Drug Pricing Program. Since then, restrictions for the...

  • Behavioral Health
  • Clinical Insights
  • Treatment
Currently available and emerging therapy options for treatment-resistant depression

Studies show that 50% of people with major depressive disorder don’t respond adequately to initial antidepressant treatment.1 Additionally, an estimated 30% of people with major depressive disorder (MDD) experience treatment-resistant...

  • Art Celebration
  • Consumer Stories
  • People-first Pharmacy Care
Genoa Art Celebration participant heals through art, helps others after losing daughter to substance use disorder

Content warning: This post discusses mental illness and substance use. Please call the Suicide and Crisis Lifeline at 988, the Substance Abuse and Mental Health Services Administration’s National Helpline at...